Keyphrases
Oxaliplatin
100%
Colon Cancer Cells
100%
Exposure-response
100%
Clonogenic Assay
60%
Heat Treatment
40%
Cell Killing
40%
IC50
40%
Emax
40%
WiDr Cell Line
40%
Antitumor Activity
20%
Drug Treatment
20%
Cytotoxicity
20%
Clinical Feasibility
20%
Hyperthermia
20%
Exposure Time
20%
Flow Cytometry
20%
Life Cycle Analysis
20%
MTT Assay
20%
Treatment Length
20%
SW620 Cells
20%
Effective Length
20%
SW620 Cell Line
20%
Oxaliplatin Resistance
20%
Cell Differences
20%
Pharmacology, Toxicology and Pharmaceutical Science
Colon Carcinoma
100%
Oxaliplatin
100%
IC50
33%
Pharmacotherapy
16%
Antitumor Activity
16%
Flow Cytometry
16%
Hyperthermia
16%
Cytotoxicity
16%
Cell-Cycle Analysis
16%